VTUS

PropThink: With a Late-Stage GI Asset and Quality Financials, VTUS Has Room for Growth

[ACN Newswire] – By Jake KingVentrus Biosciences (NASDAQ:VTUS) recently hired JP Benya as its new VP of Commercial Operations and Business Development, with the intent that Benya will play a significant role in preparing … moreView todays social media effects on VTUSView the latest stocks trending across Twitter. Click to view dashboard […]

PropThink: VEN-307 is Ideal for a Small Company to Launch, says Ventrus CEO

[ACN Newswire] – Ventrus Biosciences (NASDAQ:VTUS) believes it has hit the trifecta of anal fissure endpoints with its lead candidate VEN-307. In a 465 patient Phase III trial, CEO Russel Ellison says the company … moreView todays social media effects on VTUSView the latest stocks trending across Twitter. Click to view dashboard […]